The Complete Guide to NAD+ Precursors: Bioavailability, Clinical Evidence, and Dosing
Quick Answer
Should I take NMN or NR?
A research-backed guide to NAD+ precursors (NMN and NR) — cellular energy, DNA repair, sirtuin activation, the 2026 head-to-head trial results, dosing protocols, epigenetic aging markers, and safety profile.
What Is NAD+ and Why Does It Decline With Age?
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It plays a central role in three interconnected biological processes: cellular energy metabolism, DNA repair, and the activation of sirtuins — a family of proteins involved in regulating gene expression, stress responses, and cellular longevity pathways.
In energy metabolism, NAD+ functions as an electron carrier in the mitochondrial electron transport chain. It accepts electrons during glycolysis and the citric acid cycle, becoming NADH, and then shuttles those electrons to generate ATP — the cell's primary energy currency. Without adequate NAD+, mitochondrial efficiency declines and cells cannot sustain normal energy output.
In DNA repair, NAD+ is consumed by enzymes called PARPs (poly ADP-ribose polymerases), which detect and repair strand breaks in DNA. As DNA damage accumulates with age and environmental exposures, PARP activity increases, drawing down NAD+ stores. Other NAD+-consuming enzymes, including CD38, also draw on cellular NAD+.
Sirtuins — particularly SIRT1, SIRT3, and SIRT6 — require NAD+ as a cofactor to carry out their regulatory functions. When NAD+ levels fall, sirtuin activity declines, which affects mitochondrial biogenesis, inflammatory signaling, and the cellular stress response. This is the mechanistic basis for interest in NAD+ as a longevity-associated molecule.
Reviews of the research report that tissue and cellular NAD+ levels gradually decline with age in rodents and humans.
NMN vs NR: The Head-to-Head Comparison
Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are the two NAD+ precursors with the largest bodies of clinical research. Both are naturally occurring compounds found in small amounts in food.
Both NMN and NR have been studied in randomized human trials that measured blood NAD+. In an 8-week placebo-controlled trial of overweight but otherwise healthy adults, oral NR raised whole-blood NAD+ in a dose-dependent way. In a separate 60-day placebo-controlled trial of 80 healthy middle-aged adults, oral NMN at 300, 600 and 900 mg per day raised blood NAD+. These are two different studies in different groups, not a head-to-head comparison.
NR is one step further from NAD+ in the biosynthetic pathway: cells convert NR to NMN using nicotinamide riboside kinases, and NMN is then converted to NAD+ by NMNAT enzymes. NMN enters the cell and is converted directly to NAD+ — it is one step closer in the pathway, though both precursors ultimately require enzymatic conversion inside the cell.
In a separate randomized, double-blind, placebo-controlled trial of 120 healthy adults aged 60 to 80, a product combining NR with pterostilbene raised whole-blood NAD+ in a dose-dependent manner over eight weeks; because the product paired NR with pterostilbene, that result cannot be credited to NR alone, and the trial was run by authors affiliated with the product's maker. Direct head-to-head crossover comparisons of NMN versus NR in the same participants are limited, so claims that one precursor produces a categorically larger NAD+ increase than the other should be treated as preliminary.
The mechanistic difference between NMN and NR has been debated in the research literature. Early studies suggested NMN might be converted to NR before entering some cell types, effectively making the two precursors functionally equivalent. A 2019 mouse study identified Slc12a8 as an NMN transporter in the small intestine. This was shown in mice, and its relevance to human NMN supplementation has not been established. The clinical significance of this mechanistic distinction for human supplementation remains an area of active investigation.
The NAD precursor category has seen growing consumer and research interest, driven primarily by longevity-oriented demand.
FormulaForge does not rate NMN or NR using our standard bioavailability scale in the same way as traditional supplement forms, because the relevant outcome measure is intracellular NAD+ elevation rather than direct absorption of the precursor molecule. Both precursors have been studied in randomized human trials that measured blood NAD+.
Dosing Protocols: How Much NMN or NR Should You Take?
Clinical trials have evaluated a range of doses for both NMN and NR in humans, and several patterns have emerged from this research base.
In one randomized, placebo-controlled trial of 80 healthy middle-aged adults, NMN was given at 300, 600 or 900 mg per day for 60 days and was well tolerated. Other NMN doses have been used in research and in products, but we have not reviewed trial data for them here.
For NR, studied doses in human trials have ranged from roughly 100 mg to 2,000 mg per day. A separate eight-week randomized, double-blind, placebo-controlled trial of 120 adults aged 60 to 80 tested NR combined with pterostilbene at two doses and reported a dose-dependent rise in whole-blood NAD+; it does not isolate the effect of NR alone. Commercial NR supplements typically provide 300-500 mg per day, with research-oriented formulations offering up to 1,000 mg per day.
Brain NAD+ elevation is a research interest because neurons are among the most metabolically demanding cell types and may be particularly sensitive to NAD+ status. In a small phase I trial (30 people with newly diagnosed Parkinson's disease), 1,000 mg per day of NR for 30 days was associated with a significant but variable rise in brain NAD+ measured by magnetic resonance spectroscopy. This is a single small study in a patient population, and it does not show the same result in healthy adults.
Consult your healthcare provider before starting NMN or NR supplementation, particularly if you take medications or have any health conditions. FormulaForge supplements are not intended to diagnose, treat, cure, or prevent any disease.
Epigenetic Clock and Biological Age: Can NAD+ Precursors Affect Aging Markers?
Epigenetic clocks are mathematical models that use patterns of DNA methylation — chemical modifications on the genome that regulate gene expression without changing the DNA sequence — to estimate biological age. Unlike chronological age, biological age reflects the cumulative physiological state of an individual's cells.
FormulaForge does not make claims about NAD+ precursors reversing biological age or treating aging-related conditions. The epigenetic clock research represents emerging scientific interest in NAD+ biology — not established clinical efficacy. Individuals interested in biological age monitoring should work with a qualified healthcare provider to interpret results in the context of their overall health profile.
Other NAD+ Boosters: Niacinamide, Tryptophan, and the Salvage Pathway
NAD+ biosynthesis occurs through three distinct metabolic routes: the de novo pathway from tryptophan, the Preiss-Handler pathway from nicotinic acid (niacin), and the salvage pathway, which recycles nicotinamide back into NAD+. NMN and NR both enter the salvage pathway.
Niacinamide (nicotinamide, a form of Vitamin B3) is the product of NAD+ breakdown .
Niacinamide is recycled to NAD+ through the salvage pathway, where NAMPT is the rate-limiting enzyme. We have not reviewed human trial data on niacinamide as an NAD+ raiser.
Safety, Interactions, and What to Monitor
NMN and NR have been evaluated in multiple human safety trials and have generally shown favorable tolerability profiles at the doses studied in research settings.
NR safety data is the more extensive of the two. Human trials have evaluated doses from roughly 100 mg to 2,000 mg per day. In an 8-week randomized, placebo-controlled trial of overweight but otherwise healthy adults, NR at 100, 300 and 1,000 mg per day raised whole-blood NAD+, with no significant difference in adverse events from placebo. In a 12-week randomized trial of 40 obese men, NR at 1,000 mg twice daily produced no serious adverse events and normal safety blood tests.
In one randomized, placebo-controlled trial of 80 healthy middle-aged adults, NMN at 300, 600 and 900 mg per day for 60 days was well tolerated. Long-term controlled safety data for NMN are limited.
The human trials cited on this page lasted from 30 days to 12 weeks and were not designed to measure cancer outcomes, so they do not answer this question. People with active cancer or a history of cancer should talk with their oncologist before using NAD+ precursors.
In one NR trial cited here, LDL cholesterol did not rise, and in another, safety blood tests were normal. Specialty labs offer NAD+ blood testing; these tests are not standard clinical tests, and we do not endorse a particular provider.
Drug-interaction data for NMN and NR are limited. Tell your healthcare provider about all supplements you take, particularly if you use prescription medication.
FormulaForge supplements are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any new supplement regimen, especially if you have an existing health condition or take medications.
How we evaluate ingredient quality → Learn about our multi-factor scoring system and manufacturing standards.
Ready to formulate with NAD+ Precursors?
Build your personalized formula with research-backed dosing.
Start My FormulaFrequently Asked Questions
- Should I take NMN or NR?
- Both NMN and NR have been studied in randomized human trials that measured blood NAD+. In an 8-week placebo-controlled trial of overweight but otherwise healthy adults, oral NR raised whole-blood NAD+ in a dose-dependent way. In a separate 60-day placebo-controlled trial of 80 healthy middle-aged adults, oral NMN at 300, 600 and 900 mg per day raised blood NAD+. These are two different studies in different groups, not a head-to-head comparison. Direct head-to-head comparisons of NMN versus NR in the same participants are limited, so claims that one is categorically superior to the other should be treated as preliminary. Consult your healthcare provider to determine what makes sense for your health goals.
- How much NMN or NR should I take per day?
- In one randomized trial, NMN was given at 300, 600 or 900 mg per day for 60 days. NR trials cited on this page used doses from 100 mg to 2,000 mg per day. Starting at the lower end of the researched range and assessing tolerance before increasing is a reasonable approach. Always consult your healthcare provider before starting supplementation.
- How long does it take to see results from NMN or NR?
- In an 8-week NR trial, whole-blood NAD+ was higher within 2 weeks and the increase was maintained through the end of the study. The trials cited on this page ran from 30 days to 12 weeks. We make no claim about how soon any feeling of well-being, energy, sleep or biological age changes.
- Are there safety concerns with long-term NMN or NR use?
- The trials cited on this page, lasting from several weeks to a few months, reported no serious adverse events at up to 2,000 mg per day of NR (12 weeks) and 900 mg per day of NMN (60 days). Long-term safety data are limited. The theoretical concern about NAD+ supporting cancer cell metabolism has not been confirmed in human supplementation studies, but individuals with active cancer or cancer history should discuss this with their oncologist. Long-term safety data is limited given the relative novelty of systematic human research in this area. FormulaForge recommends periodic check-ins with your healthcare provider if using NAD+ precursors long-term.
- How can I test my NAD+ levels?
- Specialty labs offer NAD+ blood testing. These tests are not standard clinical tests, and we do not endorse a particular provider. Ask your healthcare provider whether testing makes sense for you.
- Is NMN or NR more cost-effective?
- Prices for NMN and NR vary by brand and supply. Both have been studied in randomized human trials that measured blood NAD+. Niacinamide is a different vitamin B3 form, and we have not reviewed trial data comparing it with NMN or NR.
Related Pages
References
FormulaForge formulates and sells supplements containing the ingredients discussed on this page. Form Scores and ranks are built from bioavailability data and citations for each form, and whether we sell a form does not change either. How the Form Score works.